Innova Derma, Premier Technical Services Group, Tax Systems
What’s cooking in the IPO kitchen?
Global Energy Development (GED.L)
To be renamed Nautilus Marine Services. Schedule 1 from developer and seller of hydrocarbons and related products. Reverse takeover. Raising $10.5m via a convertible. Expected 9 Feb.
Eco (Atlantic) Oil & Gas (TSX-V)
listed oil and gas exploration has announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise.
Diversified gas & Oil
According to LSE website first day of trading on AIM now expected for 30 January.
(IDP.L) 246.5p £29.2m
H1 Dec 16 trading statement from the UK developer of ‘at-home’ and clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation. H1 Financial performance has been encouraging and revenues are expected to show growth of just over 80% year-on-year on a constant currency basis to approximately £3.0m (FYJun16E £6.6m). The increase in revenue has been driven by the Company’s expansion strategy in the UK with the strong performance of Skinny Tan. H1 included the listing on the LSE, opening up the US Market and the transition of its manufacturing to the UK. One off costs to be recognised in H1. H1 strategic initiatives expected to drive top line revenue and earnings from the second half of the Company’s financial year.
Premier Technical Services Group
(PTSG.L) 84p £74.26m
The niche specialist services provider, has completed the acquisition of Nimbus, a designer, installer and maintainer of lightning protection and earthing systems based in Nottingham, for a total consideration of £1.0m, payable in cash on completion. The unaudited revenue of Nimbus for the year ended 31 December 2015 was £1.4m, producing a profit before tax of £0.3m. The unaudited net assets at 31 December 2015 were £0.3m. “The acquisition provides additional capabilities to the Group, including an attractive testing and inspection base, as well as its installation activities from which PTSG will continue to enhance its market leading offering.” FYDec16E revenue of £36.7m and £7.5m PBT.
(FDEV.L) 312.5p £106.6m
Trading update from developer of video games. Second franchise Planet Coaster launched in November 2016. “The launch received a positive reception from gamers and reviewers and by the end of December over 0.5 million paid units had been sold. We have a strong programme of updates in place for Planet Coaster which will be released through 2017 and beyond. The Group’s Elite Dangerous franchise continues to perform well. By the end of December 2016 a total of over 2.1 million paid franchise units had been sold.” “Revenue for the six months ended 30 November 2016 was approximately £18.1m, an increase of 66% when compared to the first half of last year. We expect to report EBITDA for the period of approximately £5.7m.” FYMay17E £32.5m rev, PBT £3.4m.
(TAX.L) 70.5p £53.58m
FY Dec 16 trading update from the supplier of corporation tax software and services. “The Company has performed as budgeted at the time of re-admission to AIM in July 2016 and trading and net debt for the year ended 31 December 2016 are in line with market expectations. Since Admission, the Company has strengthened its management team with a number of new appointments to drive organic and acquisitive growth while supporting the Company’s valued existing customer base.” FYDec16E rev of £5.7m and PBT of £2.2m with strong growth forecast in 2017.
(EMH.L) 43p £55.65m
EMH announced that the planned core drillhole programme was completed on time and budget, without time loss incidents. In total 17 drillholes were drilled to a summary depth of 6081 meters. Analytical results for further two drillholes at Cinovec Main confirmed or exceeded the expected lithium content and mineralization widths. The Company is also announced the appointment of a highly experienced mining executive to the role of Country Manager, Richard Pavlik. Cinovec is the largest lithium deposit in Europe and the fourth largest non-brine deposit in the world.
SQS Software Quality
(SQS.L) 622.5p £197.18m
FY Dec16 trading update from the global specialist in end-to-end software and business process quality solutions. Profitability in-line. Focus on high margin business and weaker sterling has had some impact on revenue.Substantial order intakes on digital transformation programmes in recent weeks including A €30m engagement with a major global car manufacturer;- Significant new orders and extensions from public institutions in Europe totalling €20m; A managed service contract with an insurance business worth €10m; Various multi-million US dollar orders from well known US companies.
(ING.L) 156.5p £26.5m
FY Dec16 trading update from the software and service provider to the publishing and media industry. “The Group’s financial performance continues the recovery shown in the first half of the year, with positive progress in terms of revenues, margins, costs, and cash flow. As a result, the Board is confident that the business will exceed market expectations for EBITDA and cash for the full year, with a year-end net cash balance of approximately £2 million. The Board reiterates its intention to pay a dividend of 1 pence per ordinary share for the 2016 financial year, the first dividend in the Group’s history.” FY Dec16E rev of £16.3m and PBT of £0.66m.
(INS.L) 223.5p £35.25m
FYDec16 trading update form the provider of IT solutions to the global early development healthcare market. Revenues up c.11% to £18.1m generating adjusted EBITDA of £1.2m. As previously announced, the strong performance in the majority of the business was offset by the disappointing performance of Instem Clinical and the signing of certain contracts, totalling £1.2 million, which has been delayed into 2017. Instem still expects to secure these contracts in the current year. Net cash as at 31 December 2016 was £4.1m.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.